UK Medicines Information
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Information type:
Randomised controlled trials
Source:
Lancet Public Health
Specialities:
Infection and infectious diseases | Vaccination
Summary
The meningococcal quadrivalent glycoconjugate vaccine (MenACWY-CRM) and the serogroup B vaccine (4CMenB) both reduced meningococcal carriage rates in university students in England during 12 months after vaccination, suggesting they could provide herd protection.
UKMi comment
Comment is available via the link below
Related links:
Comment